Lichen International Limited
LICN
$3.12
-$0.13-4.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -39.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -39.01% | |||
| Cost of Revenue | 0.00% | -11.61% | |||
| Gross Profit | 0.00% | -55.16% | |||
| SG&A Expenses | 0.00% | -43.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -34.17% | |||
| Operating Income | 0.00% | 16.09% | |||
| Income Before Tax | 0.00% | -53.12% | |||
| Income Tax Expenses | 0.00% | -90.72% | |||
| Earnings from Continuing Operations | 0.00% | -33.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -815.79% | |||
| Net Income | 0.00% | -35.48% | |||
| EBIT | 0.00% | 16.09% | |||
| EBITDA | 0.00% | 43.49% | |||
| EPS Basic | 0.00% | 2.71% | |||
| Normalized Basic EPS | 0.00% | -12.75% | |||
| EPS Diluted | 0.00% | 2.71% | |||
| Normalized Diluted EPS | 0.00% | -12.75% | |||
| Average Basic Shares Outstanding | 0.00% | 39.24% | |||
| Average Diluted Shares Outstanding | 0.00% | 39.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||